Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG

NCT04062656 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Adenocarcinoma of the Esophagogastric Junction

Interventions

DRUG: Nivolumab
DRUG: relatlimab
DRUG: Oxaliplatin
DRUG: Docetaxel
DRUG: 5-Fluorouracil (5-FU)
DRUG: Folic acid (FA)

Sponsor

University Hospital, Essen

Collaborators

[object Object]